Knus Accepted Into Prestigious School For Social Entrepreneurs London Health Accelerator

November 01, 2024 03:28 AM AEDT | By Pressat
 Knus Accepted Into Prestigious School For Social Entrepreneurs London Health Accelerator
Image source: Pressat
Thursday 31 October, 2024

London, UK — 31st October 2024 — knus, a dynamic health tech company dedicated to transforming mental health peer support through innovative digital solutions, is proud to announce its acceptance into the highly selective School for Social Entrepreneurs (SSE) London Health Accelerator. This esteemed program, designed to empower social enterprises addressing health inequalities and healthcare challenges, will provide knus with invaluable mentorship, industry expertise, and access to a powerful network to accelerate the impact of its mission.

The London Health Accelerator, offered by the SSE in collaboration MedCity and the UK Governments UK Shared Prosperity Fund, is tailored for social enterprises focusing on improving healthcare outcomes. The Accelerator’s unique curriculum is crafted to address the specific challenges of scaling social impact in the health sector in underserved communities.

knus is a UK-based non-profit organisation offering a free, confidential mental health peer support platform. Designed to foster a supportive community, knus connects service users with trained peer support coaches who have lived experiences in mental health challenges. The platform provides a safe online space for people to discuss topics like anxiety, depression, addiction, and bereavement, among others. Volunteer coaches, guided by professionals such as doctors and social workers, help users access resources and emotional support. Access into the SSE London Health Accelerator marks a critical milestone for knus as it looks to broaden its reach and deepen its impact within the healthcare system.

knus joins a distinguished cohort of social entrepreneurs who share a commitment to addressing healthcare disparities and enhancing community health. With the support of SSE London Health Accelerator, knus looks forward to advancing its mission of making healthcare more accessible, informed, and equitable.

About knushttps://knus.io

knus is a pioneering health tech company dedicated to empowering service users and transforming mental healthcare delivery through digital innovation. By focusing on service user centric solutions, Knus.io bridges the gap between technology and healthcare, enabling better-informed service user and enhancing health outcomes.

About the School for Social Entrepreneurshttps://www.the-sse.org/

The School for Social Entrepreneurs supports people from all backgrounds to tackle society’s biggest problems, with the vision of transforming lives and communities. Since 1997, SSE has empowered over 2,500 social entrepreneurs and social impact organisations in the UK and beyond.

About MedCityhttps://medcityhq.com

MedCity is a life sciences cluster organisation for London, fostering collaboration in health, biotech, and medtech sectors to drive innovation, investment, and talent growth. Established by the Mayor of London, MedCity connects companies, researchers, and policymakers, supporting initiatives in drug discovery, medical devices, digital health, and data science. Its mission is to strengthen London’s role as a global science hub and improve health outcomes through partnerships and strategic support.


Distributed by https://pressat.co.uk/


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.